If you notice or suspect any of these symptoms, see a healthcare professional as soon as possible
Whether your goal is to smash your weight loss goals out of the park, improve your metabolic health, gain confidence, or a combination of all three, our patients share their stories to show you just how possible this is with Wegovy
In the 48-week Phase 2 MASH trial (NCT04771273) published in the New England Journal of Medicine, histologic improvement in MASH without worsening of fibrosis occurred in up to 62% of survodutide-treated participants (at 4.8 mg) versus 14% on placebo, with a significant dose-response
Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis
* All orders are submitted by a pharmacist with a prescription, and ship directly to you from the compounding pharmacy